Search Results - Matthew A. Sleeman
- Showing 1 - 4 results of 4
-
1
-
2
IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells by Ana Camelo, Guglielmo Rosignoli, Yoichiro Ohne, Ross A. Stewart, Catherine Overed-Sayer, Matthew A. Sleeman, Richard D. May
Published in Blood Advances (2017-04-01)Get full text
Article -
3
An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation. by Stephanie Traub, Alexandra Nikonova, Alan Carruthers, Rebecca Dunmore, Katherine A Vousden, Leila Gogsadze, Weidong Hao, Qing Zhu, Katie Bernard, Jie Zhu, Michael Dymond, Gary R McLean, Ross P Walton, Nicholas Glanville, Alison Humbles, Musa Khaitov, Ted Wells, Roland Kolbeck, Andrew J Leishman, Matthew A Sleeman, Nathan W Bartlett, Sebastian L Johnston
Published in PLoS Pathogens (2013-01-01)Get full text
Article -
4
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Research in context by Bei Wang, Jacquelynn Golubov, Erin M. Oswald, Patrick Poon, Qiaozhi Wei, Clarissa Lett, Fadi Shehadeh, Matthew Kaczynski, Lewis Oscar Felix, Biswajit Mishra, Evangelia K. Mylona, Matthew F. Wipperman, Erica Chio, Sara C. Hamon, Andrea T. Hooper, Selin Somersan-Karakaya, Bret J. Musser, Christopher D. Petro, Jennifer D. Hamilton, Matthew A. Sleeman, George D. Kalliolias, Eleftherios Mylonakis, Dimitris Skokos
Published in EBioMedicine (2024-10-01)Get full text
Article
